HR729-119

In Committee

Teleabortion Prevention Act of 2025

119th Congress Introduced Jan 24, 2025

Summary

What This Bill Does

The Teleabortion Prevention Act creates a new federal criminal prohibition on chemical abortions provided in or affecting interstate or foreign commerce unless the healthcare provider physically examines the patient, is physically present at the location of the chemical abortion, and schedules a follow-up visit within 14 days after the drug is administered or used. Violating providers face a fine of up to $1,000, imprisonment for up to two years, or both. The offense does not apply when the chemical abortion is necessary to save the mother's life from a physical disorder, illness, injury, or life-endangering condition caused by pregnancy. Patients cannot be prosecuted under the new section or for conspiracy. The bill defines abortion drug, chemical abortion, attempts to provide, healthcare provider, provide, unborn child, preserves ectopic pregnancy treatment, and includes severability.

Who Benefits and How

Patients benefit from an explicit no-prosecution rule, even though access to remote medication abortion would be restricted. Anti-abortion advocates benefit because the bill requires in-person examination, provider presence, and fast follow-up before abortion drugs can be legally provided. Federal prosecutors benefit from a defined offense, penalty, and interstate-commerce hook. Patients with verified ectopic pregnancies benefit because the bill states it does not affect that treatment.

Who Bears the Burden and How

Healthcare providers who prescribe or dispense abortion drugs must physically examine the patient, be physically present at the chemical abortion location, schedule a follow-up visit within 14 days, and avoid telehealth or mail-only models that do not meet those requirements. Telehealth abortion providers face criminal fines and imprisonment risk. Reproductive-health clinics must change workflows, documentation, and follow-up scheduling. Patients seeking medication abortion may have fewer remote options and may need in-person visits to obtain drugs legally.

Key Provisions

  • Creates a federal criminal offense for knowingly providing or attempting to provide a chemical abortion without an in-person exam, provider presence, and follow-up visit scheduling.
  • Provides penalties of up to a $1,000 fine, two years imprisonment, or both for violating healthcare providers.
  • Bars prosecution of the patient under the new section or for conspiracy to violate it.
  • Provides exceptions for life-saving care and verified ectopic pregnancy treatment and adds severability.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Creates a federal criminal offense for providers who knowingly provide or attempt to provide abortion drugs without physically examining the patient, being physically present for the chemical abortion, and scheduling a follow-up visit within 14 days, while barring patient prosecution.

Key Policy Areas

Healthcare, Criminal Justice, Reproductive Health

Primary Purpose

Creates a federal criminal offense for providers who knowingly provide or attempt to provide abortion drugs without physically examining the patient, being physically present for the chemical abortion, and scheduling a follow-up visit within 14 days, while barring patient prosecution.

Policy Domains

Healthcare Criminal Justice Reproductive Health

Substantive provisions

Identified Gains
  • Patients
  • Anti-abortion advocates
  • Federal prosecutors
  • Patients with ectopic pregnancies
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Patients: ,
Federal prosecutors: ,
Anti-abortion advocates: ,
Patients with ectopic pregnancies: ,
Identified Costs
  • Healthcare providers
  • Telehealth abortion providers
  • Reproductive-health clinics
  • Patients seeking medication abortion
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Healthcare providers: ,
Reproductive-health clinics: ,
Telehealth abortion providers: ,
Patients seeking medication abortion: ,

Legislative Progress

In Committee
Introduced Committee Passed
Jan 24, 2025

Mr. Harris of North Carolina (for himself, Mr. Clyde, Mr. …

Jan 24, 2025

Referred to the House Committee on the Judiciary.

Jan 24, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Healthcare
8 mentions across 2 clauses
+2 positive -6 negative

Healthcare providers, Patients, Reproductive-health clinics

Positive-direction: Patients

Negative-direction: Healthcare providers, Reproductive-health clinics, Telehealth abortion providers

Law Enforcement
2 mentions across 2 clauses
+1 positive -1 negative

Federal prosecutors

Federal prosecutors faces effects in multiple directions

Non-Profit Institutions
1 mention across 1 clause
+1 positive

Anti-abortion advocates

Consumers
1 mention across 1 clause
-1 negative

Patients seeking medication abortion

2/3
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Criminal Justice Reproductive Health

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology